Paper of the Month - March, 2011

0 rating

Effectiveness of transition from intravenous epoprostenol to oral inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.

Melnick L, Barst RJ, Rowan CA et al.


SUBMIT AN ARTICLE